SFRP4 and urogenital neoplasm: The abnormal expression of Wnt pathway member SFRP4 and WT1 in stromal cells and that of other members in the epithelial cancer cells (Pascal et al., submitted) suggest a significant role of Wnt signaling in prostate carcinogenesis.